The Stanford-China Cardiovascular Research Symposium will take place Sept. 21-22 at the medical school’s Li Ka Shing Center for Learning and Knowledge.
The two-day conference, which is free and open to the public, will bring together a variety of experts in cardiovascular medicine from the United States and China to share knowledge that can advance heart health. The conference aims to foster communication between students, postdoctoral scholars, clinicians and researchers to share expertise in order to facilitate future collaborations between China’s leading cardiovascular treatment and research institutions and Stanford, said Joseph Wu, MD, PhD, director of the Stanford Cardiovascular Institute, which is organizing the event.
“This conference draws cardiovascular experts from many of China’s most esteemed hospitals and universities, providing a valuable opportunity to share knowledge with Stanford and U.S. experts that will improve international collaboration on cardiovascular research and clinical care,” Wu said.
One of the keynote speakers is Victor Dzau, MD, president of the National Academy of Medicine and a professor of medicine at the Duke University School of Medicine.
Topics to be discussed include: Advances in cardiac surgery, vascular surgery, peripheral arterial disease, interventional cardiology, basic science and clinical trials.
Among the other speakers are Stanford’s Joseph Woo, MD, professor of cardiothoracic surgery, who will give a talk titled “The convergence of biologic and surgical reconstructive therapies for cardiovascular diseases,” and Haibo Zhang, MD, PhD, deputy director of cardiac surgery at Beijing Anzhen Hospital, Capital Medical University, who will speak on heart failure and the heart-transplant program at his hospital.
“Sharing complementary insights to advance cardiovascular health will benefit literally billions of people worldwide, not just in the two countries,” Wu said.
The conference is sponsored in part by the Chi-Li Pao Foundation.
Registration closes Sept. 19.